Latest Breaking News On - Maha katabi - Page 2 : vimarsana.com

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Josephr youngRaymond jamesMaha katabiVera therapeutics company profileVera therapeutics incVera therapeuticsGet free reportTherapeutics stock downDirector maha katabiVera therapeutics daily

Vera Therapeutics (NASDAQ:VERA) Sees Large Volume Increase

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) saw strong trading volume on Thursday . 980,711 shares traded hands during trading, a decline of 21% from the previous session’s volume of 1,245,474 shares.The stock last traded at $43.49 and had previously closed at $41.62. Analysts Set New Price Targets A number of equities analysts have […]

Raymond jamesMaha katabiRoyal bankVera therapeutics company profileVera therapeutics incSecurities exchange commissionAmeritas investment partners incTower research capitalVera therapeuticsGet free reportDirector maha katabiExchange commissionResearch capitalInvestment partnersAmalgamated bankVera therapeutics daily

Vera Therapeutics (NASDAQ:VERA) Earns Buy Rating from Guggenheim

Guggenheim reaffirmed their buy rating on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $56.00 price target on the stock. Several other brokerages have also commented on VERA. Raymond James raised Vera Therapeutics from an outperform rating to a strong-buy rating and […]

Raymond jamesMaha katabiCantor fitzgeraldBarclays plcVanguard group incCapital partnersGoldman sachs group incVera therapeutics incVera therapeuticsFree reportDirector maha katabiSachs groupGet free reportVera therapeutics dailyNasdaq veraReiterated rating

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down on Insider Selling

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price gapped down before the market opened on Monday after an insider sold shares in the company. The stock had previously closed at $37.52, but opened at $36.63. Vera Therapeutics shares last traded at $37.81, with a volume of 45,552 shares traded. Specifically, Director Maha Katabi […]

Maha katabiRaymond jamesRoyal bankVera therapeutics incTower research capitalAmeritas investment partners incCantor fitzgeraldVera therapeutics company profileVera therapeuticsGet free reportDirector maha katabiResearch capitalInvestment partnersAmalgamated bankVera therapeutics dailyNasdaq vera

Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)

Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Maha katabiRaymond jamesCantor fitzgeraldSecurities exchange commissionAmeritas investment partners incTower research capitalRoyal bankVera therapeutics incVera therapeuticsGet free reportDirector maha katabiExchange commissionResearch capitalInvestment partnersAmalgamated bankVera therapeutics daily